Pediatrics

Positive trial results for RSV infant treatment: Sanofi

French pharmaceutical giant Sanofi announced trial results on Friday that showed its preventative treatment for respiratory syncytial virus (RSV) reduced the rate of babies being hospitalized by more than 80 percent.

Vaccination

EU watchdog backs Sanofi COVID booster jab

The EU on Thursday approved a COVID booster vaccine by French drug maker Sanofi and Britain's GSK after it gave positive results against the Omicron variant in trials.

Diseases, Conditions, Syndromes

EU regulator recommends clearing Takeda's dengue vaccine

The European Medicines Agency on Friday recommended the authorization of a dengue vaccine made by the Japanese pharmaceutical Takeda that could provide a new tool for millions worldwide against the potentially fatal disease.

page 1 from 13